Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Jan 8, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring the use of a sleep study conducted at home to monitor the effectiveness of non-invasive ventilation (NIV) in patients with Duchenne Muscular Dystrophy (DMD). The researchers want to see if they can safely and accurately measure how well the NIV is working for patients while they sleep at home. They will also look at the minimum amount of information needed to make the best treatment decisions for these patients.

To participate in this study, you must be a male patient over 18 years old who has been diagnosed with DMD and is currently using NIV. If you join the study, you will be asked to undergo a sleep study at home, where your breathing and carbon dioxide levels will be monitored overnight. This will help the researchers determine how well the NIV is working and guide future treatment options. The trial is currently recruiting participants, so if you or a loved one meet the criteria, you might consider joining.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Patients with DMD \> 18 years using NIV
• • Signing the written informed consent
• Exclusion Criteria:
• • /